Artemis Medicare Services Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: April 25, 2025, 10:32 pm

Market Cap	3,696 Cr.
Current Price	266
High / Low	350/143
Stock P/E	49.8
Book Value	57.9
Dividend Yield	0.17 %
ROCE	13.6 %
ROE	11.4 %
Face Value	1.00
PEG Ratio	0.85

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Artemis Medicare Services Ltd

Competitors of Artemis Medicare Services Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
NG Industries Ltd	53.6 Cr.	160	206/145	4.42	124	2.19 %	6.50 %	5.63 %	10.0
Global Longlife Hospital and Research Ltd	23.6 Cr.	22.5	46.4/18.3		25.9	0.00 %	2.51 %	4.72 %	10.0
Gian Lifecare Ltd	17.0 Cr.	16.4	27.0/12.1	4.15	19.2	0.00 %	29.2 %	24.6 %	10.0
Fortis Malar Hospitals Ltd	143 Cr.	76.4	98.7/51.0	186	15.9	55.6 %	3.29 %	9.12 %	10.0
Family Care Hospitals Ltd	25.7 Cr.	4.75	9.50/3.40	0.67	2.67	0.00 %	15.4 %	24.1 %	10.0
Industry Average	23,910.57 Cr	708.00		57.88	87.89	2.67%	12.26%	11.94%	9.08

All Competitor Stocks of Artemis Medicare Services Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	142	146	163	182	181	187	201	217	210	217	217	235	227
Expenses	124	129	144	158	156	163	174	184	179	181	181	193	190
Operating Profit	18	17	19	24	26	25	27	33	32	36	36	42	37
OPM %	13%	12%	12%	13%	14%	13%	14%	15%	15%	17%	16%	18%	16%
Other Income	1	1	2	1	1	2	1	2	2	2	4	8	9
Interest	3	4	4	5	5	5	6	7	8	8	8	8	8
Depreciation	5	6	6	7	8	8	9	9	10	10	10	11	11
Profit before tax	10	8	11	14	14	14	13	19	16	19	22	31	27
Tax %	36%	-57%	22%	31%	23%	23%	26%	27%	29%	28%	24%	27%	23%
Net Profit	7	13	9	10	11	10	10	14	12	14	17	23	21
EPS in Rs	0.51	1.01	0.65	0.73	0.80	0.78	0.73	1.01	0.85	1.02	1.24	1.64	1.51

Last Updated: March 3, 2025, 5:32 pm

Below is a detailed analysis of the quarterly data for Artemis Medicare Services Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is 227.00 Cr.. The value appears to be declining and may need further review. It has decreased from 235.00 Cr. (Sep 2024) to 227.00 Cr., marking a decrease of 8.00 Cr..
For Expenses, as of Dec 2024, the value is 190.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 193.00 Cr. (Sep 2024) to 190.00 Cr., marking a decrease of 3.00 Cr..
For Operating Profit, as of Dec 2024, the value is 37.00 Cr.. The value appears to be declining and may need further review. It has decreased from 42.00 Cr. (Sep 2024) to 37.00 Cr., marking a decrease of 5.00 Cr..
For OPM %, as of Dec 2024, the value is 16.00%. The value appears to be declining and may need further review. It has decreased from 18.00% (Sep 2024) to 16.00%, marking a decrease of 2.00%.
For Other Income, as of Dec 2024, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Sep 2024) to 9.00 Cr., marking an increase of 1.00 Cr..
For Interest, as of Dec 2024, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 8.00 Cr..
For Depreciation, as of Dec 2024, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 11.00 Cr..
For Profit before tax, as of Dec 2024, the value is 27.00 Cr.. The value appears to be declining and may need further review. It has decreased from 31.00 Cr. (Sep 2024) to 27.00 Cr., marking a decrease of 4.00 Cr..
For Tax %, as of Dec 2024, the value is 23.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Sep 2024) to 23.00%, marking a decrease of 4.00%.
For Net Profit, as of Dec 2024, the value is 21.00 Cr.. The value appears to be declining and may need further review. It has decreased from 23.00 Cr. (Sep 2024) to 21.00 Cr., marking a decrease of 2.00 Cr..
For EPS in Rs, as of Dec 2024, the value is 1.51. The value appears to be declining and may need further review. It has decreased from 1.64 (Sep 2024) to 1.51, marking a decrease of 0.13.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 7, 2025, 9:15 pm

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	217	261	368	402	459	503	547	563	402	545	714	845	895
Expenses	194	234	325	359	406	442	480	501	367	477	620	717	745
Operating Profit	23	27	43	43	53	60	66	62	35	68	94	128	150
OPM %	10%	11%	12%	11%	11%	12%	12%	11%	9%	12%	13%	15%	17%
Other Income	2	1	3	5	4	3	2	4	7	3	7	7	23
Interest	15	13	12	9	9	9	11	13	12	11	19	30	31
Depreciation	9	9	12	12	15	18	20	22	21	21	29	38	42
Profit before tax	0	7	21	27	32	35	37	32	9	39	53	68	100
Tax %	-0%	-0%	12%	21%	16%	24%	44%	36%	20%	16%	25%	28%
Net Profit	0	7	19	22	27	27	21	20	7	33	40	49	74
EPS in Rs	0.02	0.32	0.88	1.03	1.29	1.27	0.98	1.54	0.54	2.46	2.96	3.62	5.41
Dividend Payout %	-0%	-0%	-0%	-0%	-0%	-0%	-0%	-0%	-0%	-0%	15%	12%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	171.43%	15.79%	22.73%	0.00%	-22.22%	-4.76%	-65.00%	371.43%	21.21%	22.50%
Change in YoY Net Profit Growth (%)	0.00%	-155.64%	6.94%	-22.73%	-22.22%	17.46%	-60.24%	436.43%	-350.22%	1.29%

Artemis Medicare Services Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	12%
5 Years:	9%
3 Years:	28%
TTM:	10%

Compounded Profit Growth
10 Years:	22%
5 Years:	18%
3 Years:	98%
TTM:	63%

Stock Price CAGR
10 Years:	%
5 Years:	75%
3 Years:	81%
1 Year:	41%

Return on Equity
10 Years:	10%
5 Years:	8%
3 Years:	10%
Last Year:	11%

Last Updated: Unknown

Balance Sheet

Last Updated: April 13, 2025, 4:03 pm

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	21	21	21	21	21	21	0.00	13	13	13	13	14	14
Reserves	109	116	135	163	183	210	280	301	308	348	393	438	783
Borrowings	118	110	85	68	94	91	114	108	137	190	268	305	307
Other Liabilities	39	66	90	93	124	130	160	159	130	145	207	191	215
Total Liabilities	287	313	331	345	422	452	555	581	589	697	882	948	1,318
Fixed Assets	237	236	239	249	283	309	381	387	372	476	584	699	718
CWIP	0	0	0	1	27	43	49	56	81	64	95	33	44
Investments	0	0	0	0	0	0	0	2	4	6	12	15	15
Other Assets	50	77	91	94	112	100	124	137	132	152	192	200	541
Total Assets	287	313	331	345	422	452	555	581	589	697	882	948	1,318

Below is a detailed analysis of the balance sheet data for Artemis Medicare Services Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 14.00 Cr..
For Reserves, as of Sep 2024, the value is ₹783.00 Cr.. The value appears strong and on an upward trend. It has increased from 438.00 Cr. (Mar 2024) to ₹783.00 Cr., marking an increase of 345.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹307.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 305.00 Cr. (Mar 2024) to ₹307.00 Cr., marking an increase of 2.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹215.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 191.00 Cr. (Mar 2024) to ₹215.00 Cr., marking an increase of 24.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹1,318.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 948.00 Cr. (Mar 2024) to ₹1,318.00 Cr., marking an increase of 370.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹718.00 Cr.. The value appears strong and on an upward trend. It has increased from 699.00 Cr. (Mar 2024) to ₹718.00 Cr., marking an increase of 19.00 Cr..
For CWIP, as of Sep 2024, the value is ₹44.00 Cr.. The value appears strong and on an upward trend. It has increased from 33.00 Cr. (Mar 2024) to ₹44.00 Cr., marking an increase of 11.00 Cr..
For Investments, as of Sep 2024, the value is ₹15.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 15.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹541.00 Cr.. The value appears strong and on an upward trend. It has increased from 200.00 Cr. (Mar 2024) to ₹541.00 Cr., marking an increase of 341.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹1,318.00 Cr.. The value appears strong and on an upward trend. It has increased from 948.00 Cr. (Mar 2024) to ₹1,318.00 Cr., marking an increase of 370.00 Cr..

Notably, the Reserves (783.00 Cr.) exceed the Borrowings (307.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	22	45	53	20	58	72	41	56	27	61	129	108
Cash from Investing Activity +	-5	-12	-10	-14	-74	-67	-50	-22	-34	-106	-153	-89
Cash from Financing Activity +	-18	-21	-35	-24	19	-10	14	-33	13	44	30	-27
Net Cash Flow	-1	11	7	-18	3	-4	5	2	6	-2	7	-8

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-95.00	-83.00	-42.00	-25.00	-41.00	-31.00	-48.00	-46.00	-102.00	-122.00	-174.00	-177.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	40	41	39	49	48	40	52	50	48	47	43	36
Inventory Days	26	26	26	21	19
Days Payable	144	237	195	189	187
Cash Conversion Cycle	-78	-171	-129	-120	-120	40	52	50	48	47	43	36
Working Capital Days	-9	-70	-59	-31	-44	-53	-26	-28	-15	-10	-29	-17
ROCE %	6%	8%	14%	15%	16%	15%	14%	11%	4%	10%	11%	14%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	69.82%	69.59%	69.27%	68.91%	68.91%	68.03%	68.03%	68.03%	68.03%	67.51%	67.17%	67.17%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.07%	0.09%	0.11%	0.10%	0.16%	0.21%	0.65%
DIIs	1.10%	0.91%	0.90%	1.15%	1.37%	1.41%	1.51%	1.96%	2.61%	3.45%	3.60%	4.51%
Government	7.37%	7.34%	7.31%	7.27%	7.27%	7.18%	7.18%	7.18%	7.18%	7.12%	7.09%	7.09%
Public	21.71%	22.17%	22.53%	22.65%	22.43%	23.30%	23.18%	22.72%	22.08%	21.76%	21.93%	20.59%
No. of Shareholders	12,098	15,177	14,637	17,995	18,100	19,082	20,529	22,375	19,993	19,795	26,054	27,004

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
Bandhan Small Cap Fund	421,079	0.15	7.68	421,079	2025-04-22 17:25:42	0%
LIC MF Focused Fund	205,202	2.83	3.74	205,202	2025-04-22 17:25:42	0%
LIC MF Healthcare Fund	156,172	4.58	2.85	156,172	2025-04-22 17:25:42	0%
LIC MF Small Cap Fund	122,701	1	2.24	122,701	2025-04-22 17:25:42	0%
LIC MF Dividend Yield Fund	79,326	0.95	1.45	79,326	2025-04-22 15:57:00	0%
LIC MF Value Fund	76,393	1.27	1.39	76,393	2025-04-22 15:57:00	0%
Bandhan Midcap Fund	70,016	0.11	1.28	70,016	2025-04-22 15:57:00	0%
LIC MF Equity Savings Fund	3,888	0.45	0.07	3,888	2025-04-22 17:25:42	0%
Motilal Oswal S&P BSE Healthcare ETF	407	0.06	0.01	407	2025-04-22 17:25:42	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	1.00	1.00	1.00	10.00	10.00
Basic EPS (Rs.)	3.62	2.89	2.40	4.90	14.95
Diluted EPS (Rs.)	3.53	2.79	2.29	4.90	14.95
Cash EPS (Rs.)	6.58	5.15	4.05	20.91	31.80
Book Value[Excl.RevalReserv]/Share (Rs.)	28.46	25.37	22.23	243.05	236.99
Book Value[Incl.RevalReserv]/Share (Rs.)	33.47	30.40	27.29	243.05	236.99
Revenue From Operations / Share (Rs.)	64.67	54.98	41.91	308.51	426.82
PBDIT / Share (Rs.)	10.31	7.55	5.39	29.26	49.90
PBIT / Share (Rs.)	7.34	5.24	3.71	13.01	32.81
PBT / Share (Rs.)	5.04	3.77	2.81	5.69	23.14
Net Profit / Share (Rs.)	3.62	2.83	2.37	4.65	14.70
NP After MI And SOA / Share (Rs.)	3.62	2.88	2.40	4.90	14.95
PBDIT Margin (%)	15.94	13.73	12.86	9.48	11.69
PBIT Margin (%)	11.35	9.53	8.86	4.21	7.68
PBT Margin (%)	7.79	6.86	6.70	1.84	5.42
Net Profit Margin (%)	5.59	5.15	5.65	1.50	3.44
NP After MI And SOA Margin (%)	5.59	5.23	5.73	1.58	3.50
Return on Networth / Equity (%)	12.91	11.49	10.87	2.02	6.31
Return on Capital Employeed (%)	12.67	10.05	8.60	3.57	10.13
Return On Assets (%)	5.05	4.26	4.48	1.08	3.37
Long Term Debt / Equity (X)	0.59	0.63	0.55	0.33	0.20
Total Debt / Equity (X)	0.66	0.71	0.62	0.33	0.24
Asset Turnover Ratio (%)	0.93	0.89	0.83	0.68	0.99
Current Ratio (X)	0.97	0.82	0.91	0.92	0.74
Quick Ratio (X)	0.92	0.75	0.82	0.84	0.67
Dividend Payout Ratio (NP) (%)	12.44	0.00	0.00	0.00	0.00
Dividend Payout Ratio (CP) (%)	6.83	0.00	0.00	0.00	0.00
Earning Retention Ratio (%)	87.56	0.00	0.00	0.00	0.00
Cash Earning Retention Ratio (%)	93.17	0.00	0.00	0.00	0.00
Interest Coverage Ratio (X)	4.48	5.15	5.96	3.00	5.16
Interest Coverage Ratio (Post Tax) (X)	2.57	2.93	3.62	1.23	2.52
Enterprise Value (Cr.)	2505.47	1107.95	765.31	372.04	243.97
EV / Net Operating Revenue (X)	2.85	1.50	1.38	0.91	0.43
EV / EBITDA (X)	17.89	10.94	10.73	9.60	3.69
MarketCap / Net Operating Revenue (X)	2.63	1.24	1.10	0.71	0.32
Retention Ratios (%)	87.55	0.00	0.00	0.00	0.00
Price / BV (X)	6.06	2.72	2.08	0.91	0.58
Price / Net Operating Revenue (X)	2.63	1.24	1.10	0.71	0.32
EarningsYield	0.02	0.04	0.05	0.02	0.10

After reviewing the key financial ratios for Artemis Medicare Services Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
For Basic EPS (Rs.), as of Mar 24, the value is 3.62. This value is below the healthy minimum of 5. It has increased from 2.89 (Mar 23) to 3.62, marking an increase of 0.73.
For Diluted EPS (Rs.), as of Mar 24, the value is 3.53. This value is below the healthy minimum of 5. It has increased from 2.79 (Mar 23) to 3.53, marking an increase of 0.74.
For Cash EPS (Rs.), as of Mar 24, the value is 6.58. This value is within the healthy range. It has increased from 5.15 (Mar 23) to 6.58, marking an increase of 1.43.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 28.46. It has increased from 25.37 (Mar 23) to 28.46, marking an increase of 3.09.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 33.47. It has increased from 30.40 (Mar 23) to 33.47, marking an increase of 3.07.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 64.67. It has increased from 54.98 (Mar 23) to 64.67, marking an increase of 9.69.
For PBDIT / Share (Rs.), as of Mar 24, the value is 10.31. This value is within the healthy range. It has increased from 7.55 (Mar 23) to 10.31, marking an increase of 2.76.
For PBIT / Share (Rs.), as of Mar 24, the value is 7.34. This value is within the healthy range. It has increased from 5.24 (Mar 23) to 7.34, marking an increase of 2.10.
For PBT / Share (Rs.), as of Mar 24, the value is 5.04. This value is within the healthy range. It has increased from 3.77 (Mar 23) to 5.04, marking an increase of 1.27.
For Net Profit / Share (Rs.), as of Mar 24, the value is 3.62. This value is within the healthy range. It has increased from 2.83 (Mar 23) to 3.62, marking an increase of 0.79.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 3.62. This value is within the healthy range. It has increased from 2.88 (Mar 23) to 3.62, marking an increase of 0.74.
For PBDIT Margin (%), as of Mar 24, the value is 15.94. This value is within the healthy range. It has increased from 13.73 (Mar 23) to 15.94, marking an increase of 2.21.
For PBIT Margin (%), as of Mar 24, the value is 11.35. This value is within the healthy range. It has increased from 9.53 (Mar 23) to 11.35, marking an increase of 1.82.
For PBT Margin (%), as of Mar 24, the value is 7.79. This value is below the healthy minimum of 10. It has increased from 6.86 (Mar 23) to 7.79, marking an increase of 0.93.
For Net Profit Margin (%), as of Mar 24, the value is 5.59. This value is within the healthy range. It has increased from 5.15 (Mar 23) to 5.59, marking an increase of 0.44.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 5.59. This value is below the healthy minimum of 8. It has increased from 5.23 (Mar 23) to 5.59, marking an increase of 0.36.
For Return on Networth / Equity (%), as of Mar 24, the value is 12.91. This value is below the healthy minimum of 15. It has increased from 11.49 (Mar 23) to 12.91, marking an increase of 1.42.
For Return on Capital Employeed (%), as of Mar 24, the value is 12.67. This value is within the healthy range. It has increased from 10.05 (Mar 23) to 12.67, marking an increase of 2.62.
For Return On Assets (%), as of Mar 24, the value is 5.05. This value is within the healthy range. It has increased from 4.26 (Mar 23) to 5.05, marking an increase of 0.79.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.59. This value is within the healthy range. It has decreased from 0.63 (Mar 23) to 0.59, marking a decrease of 0.04.
For Total Debt / Equity (X), as of Mar 24, the value is 0.66. This value is within the healthy range. It has decreased from 0.71 (Mar 23) to 0.66, marking a decrease of 0.05.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.93. It has increased from 0.89 (Mar 23) to 0.93, marking an increase of 0.04.
For Current Ratio (X), as of Mar 24, the value is 0.97. This value is below the healthy minimum of 1.5. It has increased from 0.82 (Mar 23) to 0.97, marking an increase of 0.15.
For Quick Ratio (X), as of Mar 24, the value is 0.92. This value is below the healthy minimum of 1. It has increased from 0.75 (Mar 23) to 0.92, marking an increase of 0.17.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 12.44. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 23) to 12.44, marking an increase of 12.44.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 6.83. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 23) to 6.83, marking an increase of 6.83.
For Earning Retention Ratio (%), as of Mar 24, the value is 87.56. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 87.56, marking an increase of 87.56.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 93.17. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 93.17, marking an increase of 93.17.
For Interest Coverage Ratio (X), as of Mar 24, the value is 4.48. This value is within the healthy range. It has decreased from 5.15 (Mar 23) to 4.48, marking a decrease of 0.67.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.57. This value is below the healthy minimum of 3. It has decreased from 2.93 (Mar 23) to 2.57, marking a decrease of 0.36.
For Enterprise Value (Cr.), as of Mar 24, the value is 2,505.47. It has increased from 1,107.95 (Mar 23) to 2,505.47, marking an increase of 1,397.52.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.85. This value is within the healthy range. It has increased from 1.50 (Mar 23) to 2.85, marking an increase of 1.35.
For EV / EBITDA (X), as of Mar 24, the value is 17.89. This value exceeds the healthy maximum of 15. It has increased from 10.94 (Mar 23) to 17.89, marking an increase of 6.95.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.63. This value is within the healthy range. It has increased from 1.24 (Mar 23) to 2.63, marking an increase of 1.39.
For Retention Ratios (%), as of Mar 24, the value is 87.55. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 87.55, marking an increase of 87.55.
For Price / BV (X), as of Mar 24, the value is 6.06. This value exceeds the healthy maximum of 3. It has increased from 2.72 (Mar 23) to 6.06, marking an increase of 3.34.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.63. This value is within the healthy range. It has increased from 1.24 (Mar 23) to 2.63, marking an increase of 1.39.
For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 23) to 0.02, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Artemis Medicare Services Ltd as of April 28, 2025 is: 263.41

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of April 28, 2025, Artemis Medicare Services Ltd is Overvalued by 0.97% compared to the current share price 266.00

Intrinsic Value of Artemis Medicare Services Ltd as of April 28, 2025 is: 417.63

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of April 28, 2025, Artemis Medicare Services Ltd is Undervalued by 57.00% compared to the current share price 266.00

Last 5 Year EPS CAGR: 58.55%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a low average Working Capital Days of -32.58, which is a positive sign. The stock has a low average Cash Conversion Cycle of -25.17, which is a positive sign. The company has higher reserves (289.77 cr) compared to borrowings (153.46 cr), indicating strong financial stability. The company has shown consistent growth in sales (517.00 cr) and profit (35.38 cr) over the years.	The stock has a low average ROCE of 11.50%, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Artemis Medicare Services Ltd:
1. Net Profit Margin: 5.59%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 12.67% (Industry Average ROCE: 12.26%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 12.91% (Industry Average ROE: 11.94%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 2.57
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.92
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 49.8 (Industry average Stock P/E: 57.88)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.66
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Artemis Medicare Services Ltd. is a Public Limited Listed company incorporated on 18/05/2004 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L85110DL2004PLC126414 and registration number is 126414. Currently Company is involved in the business activities of Hospital activities. Company's Total Operating Revenue is Rs. 845.23 Cr. and Equity Capital is Rs. 13.59 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Hospitals & Medical Services	Plot No. 14, Delhi Delhi 110075	investor@artemishospitals.com http://www.artemishospitals.com

Management
Name	Position Held
Mr. Onkar Kanwar	Chairman & Non-Exe.Director
Dr.(Mrs.) Devlina Chakravarty	Managing Director
Mr. Neeraj Kanwar	Non Executive Director
Dr. Nirmal Kumar Ganguly	Non Executive Director
Mrs. Shalini Kanwar Chand	Non Executive Director
Dr. Sanjaya Baru	Independent Director
Ms. Deepa Gopalan Wadhwa	Independent Director
Mr. Sunil Tandon	Independent Director
Mr. Sanjib Sen	Independent Director
Dr. Subbaraman Narayan	Independent Director

FAQ

What is the intrinsic value of Artemis Medicare Services Ltd?

Artemis Medicare Services Ltd's intrinsic value (as of 28 April 2025) is ₹263.41 — 0.97% lower the current market price of 266.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 3,696 Cr. market cap, FY2025-2026 high/low of ₹350/143, reserves of 783 Cr, and liabilities of 1,318 Cr.

What is the Market Cap of Artemis Medicare Services Ltd?

The Market Cap of Artemis Medicare Services Ltd is 3,696 Cr..

What is the current Stock Price of Artemis Medicare Services Ltd as on 28 April 2025?

The current stock price of Artemis Medicare Services Ltd as on 28 April 2025 is 266.

What is the High / Low of Artemis Medicare Services Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Artemis Medicare Services Ltd stocks is ₹350/143.

What is the Stock P/E of Artemis Medicare Services Ltd?

The Stock P/E of Artemis Medicare Services Ltd is 49.8.

What is the Book Value of Artemis Medicare Services Ltd?

The Book Value of Artemis Medicare Services Ltd is 57.9.

What is the Dividend Yield of Artemis Medicare Services Ltd?

The Dividend Yield of Artemis Medicare Services Ltd is 0.17 %.

What is the ROCE of Artemis Medicare Services Ltd?

The ROCE of Artemis Medicare Services Ltd is 13.6 %.

What is the ROE of Artemis Medicare Services Ltd?

The ROE of Artemis Medicare Services Ltd is 11.4 %.

What is the Face Value of Artemis Medicare Services Ltd?

The Face Value of Artemis Medicare Services Ltd is 1.00.